Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3

Yasuhito Yahara1,2, Hiroshi Takemori3, Minoru Okada1

  • 1Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Nature Communications
|March 25, 2016
PubMed

Insights

Researchers identified salt-inducible kinase 3 (Sik3) as a key regulator of articular cartilage. Inhibiting Sik3 or using pterosin B protected mice from osteoarthritis, suggesting new therapeutic targets.

Area of Science:

  • Biomedical Science
  • Orthopedics
  • Molecular Biology

Background:

  • Osteoarthritis is a prevalent joint disorder linked to aging and articular cartilage thinning.
  • Understanding the molecular mechanisms regulating cartilage homeostasis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of salt-inducible kinase 3 (Sik3) in articular cartilage maintenance.
  • To identify potential therapeutic strategies for osteoarthritis targeting the Sik3 pathway.

Main Methods:

  • Generation of chondrocyte-specific Sik3 conditional knockout mice.
  • Administration of pterosin B, a Pteridium aquilinum compound, to mice.
  • Assessment of articular cartilage thickness, chondrocyte population, and hypertrophy.

Main Results:

  • Sik3 knockout mice exhibited thickened articular cartilage and resistance to osteoarthritis.
  • Pterosin B inhibited chondrocyte hypertrophy and protected cartilage from osteoarthritis.
  • Sik3 deletion or pterosin B treatment led to a larger chondrocyte population.

Conclusions:

  • Sik3 plays a critical role in regulating articular cartilage homeostasis.
  • Targeting Sik3, potentially with pterosin B, offers a promising therapeutic avenue for osteoarthritis treatment.

Related Concept Videos